Keynote Session: Effects of the Pandemic on Cancer Care/Future Directions of Cancer Care

doi:10.6004/jnccn.2021.5019

Jump to Content

Keynote Session: Effects of the Pandemic on Cancer Care/Future Directions of Cancer Care

Presented by:

James E. Bachman

James E. Bachman
Search for other papers by James E. Bachman in
Current site
Google Scholar
PubMed

MPA

Kim Slusser

Kim Slusser
Search for other papers by Kim Slusser in
Current site
Google Scholar
PubMed

RN, MSN

Thomas K. Varghese

Thomas K. Varghese
Search for other papers by Thomas K. Varghese in
Current site
Google Scholar
PubMed

MD, MS

Andrew Wagner

Andrew Wagner
Search for other papers by Andrew Wagner in
Current site
Google Scholar
PubMed

MD, PhD

, and

moderated by Timothy Kubal

moderated by Timothy Kubal
Search for other papers by moderated by Timothy Kubal in
Current site
Google Scholar
PubMed

MD, MBA

View More View Less

Volume/Issue:: Volume 19: Issue 5.5

Online Publication Date:: 17 May 2021

DOI:: https://doi.org/10.6004/jnccn.2021.5019

Restricted access

Get Citation Alerts

A panel of experts in healthcare administration and delivery convened virtually during the NCCN 2021 Virtual Annual Conference to discuss the effects of the pandemic on cancer care and what the future may hold. The discussion ranged from the effects of the pandemic on screening and the implications of missing early cancers to the challenges of telemedicine, the future delivery of more in-home services, and burnout among healthcare workers as hospitals and cancer centers work to rebuild for the future.

Disclosures: Dr. Bachman has disclosed receiving consulting fees from GRAIL, Inc. Dr. Wagner has disclosed receiving consulting fees from Daiichi-Sanyko Co., Deciphera Pharmaceuticals, Inc., Epizyme, Inc., and Mundipharma International. The remaining panelists have disclosed that they have no financial interests, arrangements, affiliations or commercial interests with the manufacturers of any products discussed in the article or their competitors.

Correspondence: Timothy Kubal, MD, MBA, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612. Email: timothy.kubal@moffitt.org; James E. Bachman, MPA, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 401 North Broadway, Baltimore, MD 21231. Email: jbachm15@jhmi.edu; Kim Slusser, RN, MSN, Yale Cancer Center/ Smilow Cancer Hospital, 20 York Street, New Haven, CT 06510. Email: kim.slusser@ynhh.org; Thomas K. Varghese, MD, MS, Huntsman Cancer Institute, 30 North 1900 East, #3C127 SOM, Salt Lake City, UT 84132. Email: thomas.varghese@hsc.utah.edu; and Andrew Wagner, MD, PhD, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215. Email: Andrew_Wagner@dfci.harvard.edu

Print
Save
Cite
Email this content

Share Link

Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:

https://jnccn.org/abstract/journals/jnccn/19/5.5/article-p593.xml
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully